Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-88.89	16.48	-148.35
Graham Fair Price	160.13	53003.58	20375.57
PEG	-97.73	-0.01	0.57
Price/Book	-0.84	0.50	0.51
Price/Cash Flow	-95.77	-35.32	-18.04
Prices/Earnings	-84.92	9.97	-66.12
Price/Sales	-4.87	1.02	1.07
Price/FCF	-95.77	-35.32	-18.04
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	18.67	0.35	0.29
Operating Margin	204.71	0.04	-0.01
ROA	557.95	< 0.005	< 0.005
ROE	< 0.005	0.01	557.40
ROIC	< 0.005	0.01	495.11
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.21	-99.70
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.26	4.22	234.26
EPS QOQ	-1.16	7.67	563.69
FCF QOQ	-2.11	0.49	-77.00
Revenue QOQ	-0.11	0.06	-46.00
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	98.11	105.06	7.08
Days Sales Outstanding (DSO)	39.28	40.76	3.77
Inventory Turnover	0.92	0.86	-6.61
Debt/Capitalization	0.28	0.27	-2.94
Quick Ratio	0.92	0.99	7.42
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	98187.49	99617.98	1.46
Cash	37539.58	40865.38	8.86
Capex	-4162.47	-3396.68	18.40
Free Cash Flow	-2754.40	-1415.47	48.61
Revenue	46301.72	48964.77	5.75
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.50	1.59	6.16
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-55.41	5.52	-90.03
Naive Interpretation	Member

06 - Financial Health · Weak

Rating